Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · IEX Real-Time Price · USD
1.160
+0.050 (4.50%)
At close: May 7, 2024, 4:00 PM
1.173
+0.013 (1.12%)
Pre-market: May 8, 2024, 8:43 AM EDT
Aptevo Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Maintains $3,036 → $880 | Buy | Maintains | $3,036 → $880 | +75,762.07% | May 13, 2022 |
Roth Capital | Roth Capital | Strong Buy Maintains $2,816 → $2,200 | Strong Buy | Maintains | $2,816 → $2,200 | +189,555.17% | May 28, 2021 |
Piper Sandler | Piper Sandler | Buy Maintains $1,408 → $3,036 | Buy | Maintains | $1,408 → $3,036 | +261,624.14% | Nov 11, 2020 |
Roth Capital | Roth Capital | Strong Buy Initiates $7,392 | Strong Buy | Initiates | $7,392 | +637,141.38% | Apr 11, 2018 |
Piper Sandler | Piper Sandler | Buy Initiates $4,312 | Buy | Initiates | $4,312 | +371,624.14% | Sep 9, 2016 |